PerkinElmer, Inc.’s PKI Oxford Immunotec recently announced that the FDA approved the use of the T-Cell Select reagent kit to automate its T-SPOT.TB test workflow for in-vitro diagnostic (IVD) use by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback